Method of interfering with gene expression in mammalian post-implantation embryos

Details for Australian Patent Application No. 2003252850 (hide)

Owner Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.

Inventors Haubensak, Wulf Eckhard; Calegari, Federico; Buchholz, Frank; Huttner, Wieland B

Agent Griffith Hack

Pub. Number AU-A-2003252850

Priority 02 02 2922.5 10.10.02 EP

Filing date 7 October 2003

Wipo publication date 29 April 2004

International Classifications

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C12N 015/89 Mutation or genetic engineering

Event Publications

23 October 2003 Complete Application Filed

  Priority application(s): 02 02 2922.5 10.10.02 EP

29 April 2004 Application Open to Public Inspection

  Published as AU-A-2003252850

22 March 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003252851-Reversible boronate complexes of 1,2-cis-diol cyclic-peptides

2003252849-Expanded information capacity for existing communication transmission systems